No matches

Educational Resources

ADVENT On Air | Breath, Blood, and Beyond: The Prognostic Power of Biomarkers in Asthma Across Ages

Pulmonology

21 min

Podcast

ADVENT On Air | Disease Modification in Severe Asthma: Framework, Assessment, and Clinical Impact

Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?

Dermatology

3 min

expert video

Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?

Dupilumab Reduces Total IgE and Allergen-Specific IgE in a Real-World Study of Pediatric Patients With AD and Type 2 Comorbidities

Dermatology

5 min

expert video

Dupilumab Reduces Total IgE and Allergen-Specific IgE in a Real-World Study of Pediatric Patients With AD and Type 2 Comorbidities

Differential Effects of Dupilumab and JAK Inhibitors on CCL17 (TARC) in Patients With AD

Dermatology

4 min

expert video

Differential Effects of Dupilumab and JAK Inhibitors on CCL17 (TARC) in Patients With AD

The Effect of Dupilumab on the Atopic March and Risk of Nonatopic Comorbidities in Pediatric Patients With AD

Dermatology

4 min

expert video

The Effect of Dupilumab on the Atopic March and Risk of Nonatopic Comorbidities in Pediatric Patients With AD

Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment

Dermatology

4 min

expert video

Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment

Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD

Dermatology

5 min

expert video

Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD

Which Biomarkers of AD Might Be Robust Enough to Be Evaluated as a Measure of Disease Modification?

Dermatology

4 min

expert video

Which Biomarkers of AD Might Be Robust Enough to Be Evaluated as a Measure of Disease Modification?

Atopic Dermatitis and the Growing Evidence for Its Association with Various Non-Atopic Systemic Diseases

Dermatology

2 min

expert video

Atopic Dermatitis and the Growing Evidence for Its Association with Various Non-Atopic Systemic Diseases

Atopic Dermatitis and the Risk of Developing Other Atopic Diseases

Dermatology

3 min

expert video

Atopic Dermatitis and the Risk of Developing Other Atopic Diseases

Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention

Dermatology

5 min

expert video

Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChileChange country/region